An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease

NCT00632736 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

419

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease
Parkinson's Disease

Interventions

DRUG: Ropinirole XL (formerly CR)

Sponsor

GlaxoSmithKline